NCT02964338 · Interventional trial
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
Overall registry status Terminated
Phase 3
Conditions Chronic Cluster Headache
Delaware Valley sites
- Teva Investigational Site 13824 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory